Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Retained Earnings (2017 - 2025)

Catheter Precision (VTAK) has disclosed Retained Earnings for 9 consecutive years, with -$303.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Retained Earnings fell 5.96% to -$303.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$303.8 million, a 5.96% decrease, with the full-year FY2024 number at -$292.4 million, down 6.04% from a year prior.
  • Retained Earnings was -$303.8 million for Q3 2025 at Catheter Precision, down from -$301.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$160.4 million in Q1 2021 to a low of -$303.8 million in Q3 2025.
  • A 5-year average of -$244.3 million and a median of -$274.1 million in 2023 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: plummeted 4011050.0% in 2021, then fell 2.52% in 2024.
  • Catheter Precision's Retained Earnings stood at -$178.3 million in 2021, then decreased by 15.07% to -$205.1 million in 2022, then plummeted by 34.4% to -$275.7 million in 2023, then fell by 6.04% to -$292.4 million in 2024, then fell by 3.92% to -$303.8 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Retained Earnings are -$303.8 million (Q3 2025), -$301.5 million (Q2 2025), and -$296.4 million (Q1 2025).